Skip to content

Blood-Brain Barrier function: The key to successful cognitive aging?

Blood-Brain Barrier function: The key to successful cognitive aging? - Blood-Brain Barrier function and cognitive aging.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47086
Enrollment
61
Registered
2017-03-01
Start date
2017-05-22
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age-related decline in mental ability. Blood-Brain Barrier leakage

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Informed consent before participation - Participation in 12-year follow-up of the MAastricht Aging Study - Mini-Mental State Examination score >= 25 - Disability Assessment for Dementia score > 90%

Exclusion criteria

Exclusion criteria: - Contraindications for scanning (e.g. brain surgery, cardiac pacemaker, metal implants, claustrophobia, large body tattoos) - Contraindications for the gadolinium-containing contrast agent (renal failure) as determined by the estimated Glomerular Filtration Rate

Design outcomes

Primary

MeasureTime frame
- Episodic memory: Verbal Learning Test, delayed recall - Hippocampal volume - Blood-Brain Barrier leakage

Secondary

MeasureTime frame
Other measures of cognitive performance ( for post-hoc analyses): - Learning: Verbal Learning Test, immediate recall - Basic processing speed: Letter-Digit Substitution Test - Complex information processing: Stroop Color-Word Test - Global cognition: Mini-Mental State Examination Other measures of radiologically visible brain tissue abnormalities (for post-hoc analyses): - Cortical atrophy - White Matter Hyperintensities - Small cortical infarcts - Lacunes - Microbleeds - Enlarged perivascular spaces - White matter integrity

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)